bpc-157 dosing protocols protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved BPC-157 Guide: Mixing, Dosage and
Description
BMC Complement Altern Med (2013) 13:103
doi: 10.4103/jrpp.jrpp_75_21
This makes it particularly promising for those dealing with IBS, IBD, leaky gut, and SIBO
Richard Frye and colleagues, used relatively high doses of folinic acid
Alternate sides across injections
Since peptides usually arent well-absorbed in the digestive system, their effects are often limited when taken orally, It is important to note that the same may apply to BPC-157 and it may only have local effects on the stomach when taken orally
